Wczytywanie kursów wyceny...
Prognoza
Nie mamy danych analityków dla tej spółki.
Wiadomości Przejdź do aktualności
DocCheck reports preliminary 2025 results: revenue and EBIT rise
DocCheck expects 2025 revenue of between €55.1 million and €55.4 million (previous year: €53.8 million) and EBIT of €7.8 million to €8.1 million (previous year: €6.6 million), putting EBIT above the most recently adjusted forecast. The cause is a better-than-expected business performance in the fourth quarter of 2025. Cash and cash equivalents fell to €14.5 million (previous year: €17.0 million); earnings per share cannot yet be quantified. For 2026 the company expects organic growth in an economically challenging environment. » Więcej na finanzen.net
DocCheck reports preliminary nine-month figures: revenue and EBIT increased
The DocCheck Group generated revenue of €39.7 million in the first nine months of 2025 (previous year: €37.5 million) and an EBIT of €5.5–5.8 million (previous year: €3.5 million). The revenue forecast for 2025 remains €50.0–55.0 million, while the earnings forecast was raised from €5.0–5.5 million to €6.5–6.8 million. Liquid funds amounted to €14.9 million at the reporting date (previous year: €15.8 million); statements on earnings per share are not yet possible. » Więcej na finanzen.net
Historyczne dywidendy Dywidendy
Wszystkie wskaźniki dywidendowe Wszystkie wskaźnikiDane finansowe spółki
| (EUR) | grudzień 2025 | |
|---|---|---|
| Przychody | 28,77 mln | - |
| Zysk brutto | 6,39 mln | - |
| Zysk netto | 2,88 mln | - |
| EBITDA | 5,9 mln | - |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 55,81 mln € |
Liczba akcji | 5,07 mln |
Maksimum/minimum z 52 tygodni | 15,90 € - 10,60 € |
Stopa dywidendy | 9,01% |
Dywidendy TTM | 1,00 € |
Beta | 0,90 |
C/Z (PE Ratio) | 10,48 |
PEG (PEG Ratio) | 10,90 |
C/WK (PB Ratio) | 1,34 |
C/S (PS Ratio) | 1,00 |
Profil spółki
Die DocCheck AG bietet Marketing-, Customer Relationship Management- und E-Commerce-Dienstleistungen für den Gesundheitssektor in Europa an. Das Unternehmen betreibt das DocCheck-Portal für den Informationsaustausch im Internet sowie Online- und E-Commerce-Services für Akteure im Gesundheitsmarkt. Darüber hinaus entwickelt und implementiert es Kommunikationsstrategien für neue und traditionelle Medien im Gesundheitswesen und Business-to-Business-Sektor und fördert Startups im Gesundheitswesen durch Seed-Finanzierung. Die DocCheck AG hat ihren Sitz in Köln, Deutschland.
| Nazwa | DocCheck |
| CEO | Frank Nicolas Antwerpes |
| Siedziba | Cologne,
nw Niemcy |
| Strona internetowa | |
| Sektor | Technologie informacyjne |
| Branża | Usługi IT |
| Debiut giełdowy | 17.04.2020 |
| Pracownicy | 414 |
Symbole giełdowe
| Giełda | Symbol |
|---|---|
XETRA | AJ91.DE |
Frankfurt | AJ91.F |
Düsseldorf | AJ91.DU |
SIX | AJ91.SW |
München | AJ91.MU |
